HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 01/18/2013 -- Solazyme Inc (NASDAQ:SZYM) tumbled 9.23% after Reuters’ reported that the U.S. biofuel company announced suggested offering of $100 million of convertible senior subordinated notes.
Solazyme, Inc. operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels. The Company also offers marine and microaquatic compounds for health and wellness products.
Can SZYM Bounce Back? Find Out Here
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) shares fell 6 percent on nearly ten-times the average daily volume Thursday. The company priced an offering of 6.7 million shares at $7.50 a share, which was a 7.6% discount at the close of trading Wednesday.
AVEO Pharmaceuticals, Inc. is a cancer therapeutics company discovering, developing and commercializing targeted cancer therapies. The Company’s Human Response Platform, a method of building preclinical models of human cancer, provides the Company with insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics.
Can AVEO Recover After The Recent fall? Find Out Here
Celsion Corporation (NASDAQ:CLSN) shares declined 10 percent on more than twice the average daily volume Thursday. Analysts at Brean Capital have recently downgraded the company's rating to "sell" from "buy."
Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer. As of December 31, 2011, the Company's product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study), a Phase II clinical trial for colorectal liver metastasis (CRLM) and a Phase II clinical trial for recurrent chest wall breast cancer.
Can CLSN Jump Again? Find Out Here
Power One Inc. (NASDAQ:PWER) is a designer and manufacturer of inverters for the renewable energy industry. Shares of the company 10 percent on nearly 5 million shares traded Thursday. Fourth quarter revenue is expected to below their previously estimated range of $210 million to $230 million.
Power-One, Inc. is a designer and manufacturer of inverters for the renewable energy industry. It makes alternating current/direct current (AC/DC) and direct current/ direct current (DC/DC) power supplies, converters, and power management products for the servers, storage, networking, network power systems and industrial markets.
How Should Investors Trade PWER Now? Find Out Here
Theravance Inc (NASDAQ:THRX) slipped 7.81% and closed at $20.97 on a traded volume of 2.58 million shares. The Company announced the pricing of $250 million aggregate principal amount of 2.125% convertible subordinated notes due 2023 in an underwritten public offering. The Company has also granted the underwriters an option to purchase up to $37.5 million aggregate principal amount of additional notes. The offering is scheduled to close on January 24, 2013. BofA Merrill Lynch is acting as the sole book-running manager for the offering.
How Should Investors React To THRX Now? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)